Sarepta Therapeutics, Inc. ( NASDAQ: SRPT) Strategic Restructure and ELEVIDYS Label Update Conference Call July 16, 2025 4:30 PM ET Douglas S. Ingram - President, CEO & Director Ian Estepan - ...

Key Takeaways A new IVF method helped eight babies avoid inherited mitochondrial diseasesThe babies were born using DNA from ...

In a groundbreaking UK first, eight healthy babies have been born using an IVF technique that includes DNA from three ...

On an investor call Friday, analysts grilled the company over its apparent lack of transparency on the matter.

The genetic material from the donor makes up less than 1% of the baby born by using the experimental IVF technique.

A pioneering IVF technique combining DNA from three people to protect a baby from a rare genetic disease has been used in ...

The study revealed that people with these genetic changes were found to be more than twice as likely to develop heart failure ...

It is trying to treat a devastating lifelong disease by fixing it at its source. We are able to fix the actual genetic ...

The groundbreaking procedure creates IVF embryos with DNA from three people so that children can prevent inheriting incurable genetic disorders. The case study has been published in The New England ...

The UK's pioneering licensed IVF technique to reduce the risk of mitochondrial diseases carried out in Newcastle has seen ...

Fragile X disorders include two distinct conditions: fragile X syndrome (the most common single-gene cause of developmental ...